Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with TNYA: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
TNYA
Tenaya Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
TNYA
Tenaya Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
TNYA, dashed
Supply-chain overlap
Revenue flow
TNYA: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only TNYA
2
ALNY
Alnylam Pharmaceuticals
customer
—
California Institute for Regenerative Medicine (CIRM)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.13
· delayed
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
TNYA
Tenaya Therapeutics, Inc.
Change
0.36
▲
+13.96%
· post 0.36
· delayed
After hours
Nov 6 '26
delayed
Mkt cap
$72.0M
Revenue
$2M
Q3 FY26
Revenue
—
vs
Compare
After hours
Nov 6 '26
delayed
AMGN
Amgen Inc
vs
TNYA
Tenaya Therapeutics, Inc.
460.55
▲
+0.06%
post 460.13
delayed
Price
0.36
▲
+13.96%
post 0.36
delayed
$249.0B
Mkt cap
$72.0M
Q3 FY26
$10.4B
Revenue
$2M
Q3 FY26
FY25
$36.8B
Revenue
—
Change
Change
AMGN
460.55
▲
+0.06%
vs
TNYA
0.36
▲
+13.96%
After hours
Nov 6 '26
delayed